NIH Grant Application Cap: What Changed and Why

• Two different NIH caps, explained
• Why NIH is doing this: the portfolio-management rationale
• Answer-first: common questions on the NIH grant application cap
• Practical workarounds for multi-PI labs
• Implications for institutions and research offices
• What’s next

The NIH grant application cap is no longer a single rule. Since September 2025, principal investigators (PIs) have faced a firm limit on how many applications they can submit each year. As of June 2026, NIH is now consulting on a second, separate limit — this time on how many grants a PI can hold at once. The two policies are frequently conflated in coverage, but they operate on different mechanisms, timelines, and parts of a research office’s workload.

Two different NIH caps, explained

The first cap is already in force. Effective 25 September 2025, NIH limits each principal investigator (PI) or multiple-PI (MPI) team member to a maximum of six new, renewal, resubmission, or revision applications per calendar year. The limit applies per PI, not per institution, and resubmissions count toward the total — so a PI who submits three new applications and then resubmits two after a first review has used five of six slots.

The cap excludes R13 conference grants and T-series training activity codes. Critically for multi-PI labs, it also excludes collaborative submissions where a researcher is listed only as a co-investigator or other senior/key personnel rather than as PI or MPI. NIH told Inside Higher Ed that only 1.3% of applicants submitted more than six PI/MPI applications in 2024 — the vast majority of investigators were never going to be affected by the ceiling itself.

The second cap is still a proposal. On 8 June 2026, NIH published NOT-OD-26-086, an RFI seeking comment on a policy that would cap the number of simultaneous Research Project Grants (RPGs) a single PI can hold, with options of two, three, or four concurrent awards. This is a portfolio cap, not a submission cap — it would restrict how many active RPGs a PI can run at once, regardless of how many applications they submitted to get there. Science reported that a three-RPG limit was modelled to free roughly $2 billion and support around 3,020 additional investigators, while a two-RPG cap was modelled to free a larger sum, cited at roughly $3.5 billion. The comment period is open until 3 August 2026.

Why NIH is doing this: the portfolio-management rationale

Both policies are framed by NIH as portfolio-management measures rather than budget cuts. The submission cap arrived alongside a companion policy on AI-generated content: NIH will not treat applications “substantially developed by AI” as original ideas of the applicant, and post-award detection can trigger a referral to the Office of Research Integrity alongside cost disallowance or termination. NIH told reporters the pairing was meant to stop high-volume, AI-assisted submissions from overwhelming peer review — not to reduce the number of investigators it funds.

The concurrent-award RFI targets a different bottleneck: funding concentration. NIH’s own modelling, reported by Science, suggests a relatively small number of well-funded PIs hold a disproportionate share of active RPGs, and capping simultaneous awards at two, three, or four would redistribute billions toward early- and mid-career investigators who currently hold zero or one RPG — a structural-limit approach also used in eligibility rules at other national funders.

• The submission cap manages review-system load.
• The proposed concurrent-award cap manages funding concentration.
• Neither policy, as currently described, changes the NIH salary cap (set at $228,000 for 2026), which governs allowable reimbursed salary under an award, not how many awards a PI may hold.

Answer-first: common questions on the NIH grant application cap

What is the maximum number of applications for NIH?

Since 25 September 2025, each principal investigator or multiple-PI team member may submit a maximum of six new, renewal, resubmission, or revision applications per calendar year. Conference (R13) and training (T-series) applications are excluded, as are submissions where the researcher is listed only as a co-investigator rather than PI or MPI.

What is the new NIH cap for 2026?

There are two distinct 2026 developments, and they are easily confused with the unrelated NIH salary cap ($228,000 for 2026). The application-submission cap (six per year) took effect in 2025 and remains active. In June 2026, NIH separately opened an RFI, NOT-OD-26-086, proposing to cap how many concurrent RPGs a single PI may hold, with comments due by 3 August 2026.

Does the application cap include co-investigators and multi-PI teams?

No. The six-application limit counts applications where a researcher is listed as PI or MPI. Collaborative submissions naming a researcher only as a co-investigator or other senior/key personnel do not count toward that individual’s cap, which is the main structural workaround available to multi-PI labs today.

When does the NIH RFI comment period close?

The public comment period for NOT-OD-26-086, the proposal to cap concurrent RPGs per PI, closes on 3 August 2026. Institutions, scientific societies, and individual investigators can submit input directly to NIH before that deadline, ahead of any final policy decision.

Practical workarounds for multi-PI labs

Research administrators advising multi-PI groups have several concrete levers under the current (submission-cap) rules:

• Restructure authorship roles deliberately. Only PI/MPI-listed applications count toward the cap, so labs with more ideas than headroom can route some proposals through a co-investigator or senior/key personnel role for researchers who have used their six slots.
• Sequence resubmissions carefully. Resubmissions count toward the same total as new submissions, so a PI planning two new R01s and a resubmission must track all three against the ceiling from the start of the cycle, not treat resubmission as “free”.
• Front-load the strongest applications. With a hard ceiling of six, strategy shifts from “submit broadly” toward prioritising the highest-confidence proposals for limited PI/MPI slots, using non-PI collaborative roles for higher-risk ideas.
• Track activity codes against the exclusion list. R13 conference grants and T-series training awards fall outside the cap entirely; labs running these should confirm applications aren’t wrongly counted against the six-application limit.
• Watch the RFI, not just the final rule. With the concurrent-award cap open for comment until 3 August 2026, institutions with PIs holding three or more active RPGs have a narrow window to model exposure before any threshold is finalised.

Implications for institutions and research offices

For sponsored-programmes offices, the practical burden shifts from “how many can we submit” to “how do we allocate scarce PI slots.” Portfolio dashboards need to track each PI’s six-application count in real time, since resubmissions and revisions from earlier in the year silently consume capacity. It also raises internal equity questions: early-career PIs who have not yet hit historical submission volumes are effectively unconstrained, while a small number of high-output senior PIs may need support prioritising which six applications matter most.

If the concurrent-award cap is adopted, the implication is larger still. Research offices would need to model which currently-funded PIs already exceed a prospective two-, three-, or four-RPG ceiling, and plan succession — including early-career co-investigators who could be elevated to PI on a renewal. Both policies also interact with the NIH Grants Policy Statement’s existing budget-deviation rules, under which cost-category deviations of 25% or more from an approved budget may require prior sponsor approval; institutions restructuring PI roles to manage the cap should route resulting scope changes through that existing mechanism.

What’s next

The six-application submission cap is settled policy, unlikely to be revisited before NIH gathers a full year of compliance data. The concurrent-award RFI is the item to watch: with comments open until 3 August 2026 and modelled effects ranging from roughly $2 billion (a three-RPG limit) to roughly $3.5 billion (a two-RPG limit) in redistributed funding, the threshold NIH eventually chooses will materially change how research-intensive institutions structure PI status on renewals. Research administration offices tracking funder-mandate changes should treat the comment period as an active planning window, not a wait-and-see notice — the final policy is likely to arrive with limited transition time once published.